News

Bruce D. Steel has served as BioMed Ventures Managing Director since September 2010. From 2005 until its acquisition in 2008, Bruce was Chief Executive Officer and Co-Founder of Rincon Pharmaceuticals, a genetic engineering biotechnology and biofuels company. Bruce was also previously Chief Business Officer at Anaphore and Head of Corporate Development at Ambit Biosciences. He received his Bachelor of Arts Degree from Dartmouth College and his Masters of Business Administration Degree from the Marshall School of Business at the University of Southern California. Mr. Steel holds the designation of Chartered Financial Analyst.